From The Globe and Mail:
Death of a Wonder Drug
It was nicknamed a "super Aspirin" when it hit the market five years ago, billed as an early blockbuster of the biotech era, a remarkably safe anti-inflammatory drug and painkiller bound to be a hit with aging baby boomers.
Merck & Co. Inc. first developed Vioxx as a new class of arthritis medication. But it quickly landed in medicine cabinets as a treatment for everything from muscle aches to menstrual cramps, with 3.4 million prescriptions filled in Canada last year, and 84 million people taking it around the world.
Wednesday, October 06, 2004
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment